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Tiziana Pivettaa and Elisa Vallettaa
The tetrahedral S-coordinated complex [Zn(MeImHS)4](ClO4)2, synthesised from the reaction of [Zn-
(ClO4)2] with methimazole (1-methyl-3H-imidazole-2-thione, MeImHS), reacts with triethylamine to yield
the homoleptic complex [Zn(MeImS)2] (MeImS = anion methimazole). ESI-MS and MAS
13C-NMR experi-
ments supported MeImS acting as a (N,S)-chelating ligand. The DFT-optimised structure of [Zn(MeImS)2]
is also reported and the main bond lengths compared to those of related Zn-methimazole complexes.
The complex [Zn(MeImS)2] reacts under mild conditions with methyl iodide and separates the novel
complex [Zn(MeImSMe)2I2] (MeImSMe = S-methylmethimazole). X-ray diﬀraction analysis of the complex
shows a ZnI2N2 core, with the methyl thioethers uncoordinated to zinc. Conversely, the reaction of [Zn-
(MeImS)2] with hydroiodic acid led to the formation of the complex [Zn(MeImHS)2I2] having a ZnI2S2 core
with the neutral methimazole units S-coordinating the metal centre. The Zn-coordinated methimazole
can markedly modify the coordination environment when changing from its thione to thionate form and
vice versa. The study of the interaction of the drug methimazole with the complex [Zn(MeIm)4]
2+ (MeIm =
1-methylimidazole) – as a model for Zn-enzymes containing a N4 donor set from histidine residues –
shows that methimazole displaces only one of the coordinated MeIm molecules; the formation constant
of the mixed complex [Zn(MeIm)3(MeImHS)]
2+ was determined.
Introduction
Zinc is an essential metal ion for living organisms, its presence
being fundamental in catalytic, structural, and regulatory bio-
logical processes.1 Since the discovery in 1939 that the enzyme
carbonic anhydrase contains stoichiometric amounts of zinc,1c
more than 3000 proteins which must bind to zinc for proper
functioning have been identified.1d,e A wide variety of meta-
bolic processes which depend on zinc for activity have been
identified and studied, including the synthesis and degra-
dation of carbohydrates, lipids, nucleic acids and proteins.2
Flexibility in the choice of ligand (cysteine, histidine, aspartate
or glutamate) and coordination geometry leads to diverse
Zn(II) binding sites in zinc-metalloenzymes, rendering possible
a range of important biological roles.3 Zinc coordination sites
in proteins have been classified into four categories: catalytic,
cocatalytic, interface, and structural.4 In the former case, most
catalytic zinc sites contain at least one water molecule in
addition to three or four amino acid residues; the water mole-
cule site can be the target of inhibitors such as anions, sulpho-
namides, and neutral organic molecules.5 For these reasons,
the exposure to coordinating drugs like methimazole
(1-methyl-3H-imidazole-2-thione; MeImHS) (Fig. 1), which is
currently the standard treatment for Graves’ disease,6 can
potentially interact/interfere with zinc buﬀering systems and
Zn-metalloenzyme activities7 either causing zinc deficiency
Fig. 1 Ligands discussed in this paper: methimazole (MeImHS), its
anion form (MeImS), S-methylmethimazole (MeImSMe), and 1-methyl-
imidazole (MeIm).
†Electronic supplementary information (ESI) available: Electrospray Ionisation
Mass Spectrum (ESI-MS) data, DFT calculated bond lengths (Å) and angles (°)
for the complex [Zn(MeImS)2] and comments on the optimised structure and
MAS 13C-NMR spectrum of [Zn(MeImS)2]. CCDC 1051219 and 1051220. For ESI
and crystallographic data in CIF or other electronic format see DOI: 10.1039/
c5dt00917k
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and/or potentially reducing the eﬃcacy of the drug.7 The rich
coordination chemistry of methimazole with transition metals
has previously been investigated in detail.8–10 Methimazole
can bind a metal ion as a neutral species (via the thione
sulphur atom) or in its anionic form (as a monodentate
species via either the thionate sulphur atom, the thioamido
nitrogen atom, or as an ambidentate ligand via a variety of
bonding modes) (Fig. 2).
In previous studies, we investigated the reactivity of methi-
mazole with liquid mercury and zinc powder obtaining
complexes of stoichiometry [Hg2(MeImHS)2I4] and
[Zn(MeImHS)2I2] whose X-ray crystal structures show the
neutral methimazole S-binding the metal centre and the for-
mation of intermolecular hydrogen bonding via C(4)H, N–H,
and N–Me groups.11
Although the drug methimazole has been marketed since
1950, its interaction with zinc ions has received little attention
to date. In this context, the synthesis and characterisation of
zinc complexes with (N,S)-donor molecules provide infor-
mation for the structure prediction and reactivity of Zn-metal-
loproteins and -metalloenzymes. In this study, the X-ray crystal
structures of the complexes [Zn(MeImHS)4](ClO4)2 and
[Zn(MeImSMe)2I2] are reported; the optimised structure of the
complex [Zn(MeImS)2] has been proposed on the basis
of density functional theory (DFT) calculations. The complex
[Zn(MeImS)2] featuring a ZnN2S2 core is of interest in the study
of S-alkylation of zinc-thiolates in biological processes: the
electrophilic addition of CH3
+ and H+ to the coordinated
MeImS anions is discussed. Moreover, the system methima-
zole-[Zn(MeIm)4](ClO4)2 (MeIm = 1-methylimidazole), where
the Zn-complex acts as a model for Zn-enzymes containing a
N4 donor set from histidine residues, has been investigated.
Results and discussion
Synthesis, structure characterization and reactivity of the
complexes [Zn(MeImHS)4](ClO4)2 and [Zn(MeImS)2]
A search in the Cambridge Structural Database shows that
only a limited number of zinc-methimazole complexes have
been structurally characterised to date (Table 1). In all of the
reported complexes but one, the methimazole acts as a neutral
ligand binding to the Zn(II) ion via the sulphur atom, whereas
in the case of the complex [Zn4O(MeImS)6] each anionic methi-
mazole ligand bridges two zinc ions via the sulphur atom and
the nitrogen atom. Metal complexes with MeImS in (N,S)-brid-
ging/chelating mode are quite scarce in the literature.8,9 Bell
et al. reported on the synthesis of the complex [Hg(MeImS)2],
15
failing, however, to obtain a crystalline sample. For the
synthesis of the homoleptic complex [Zn(MeImS)2] we further
simplified the synthetic procedure proposed by Bell15 for
the mercury analogue by reacting the cationic complex
[Zn(MeImHS)4]
2+ with a base.
The synthesis of the complex [Zn(MeImHS)4](ClO4)2 was
accomplished by reacting Zn(ClO4)2·6H2O with MeImHS
(1 : 4 molar ratio) in EtOH/H2O. X-ray diﬀraction analysis was
performed on a single crystal and data collection and refine-
ment parameters are summarised in Table 2. The Zn atom of
the [Zn(MeImHS)4]
2+ cation is located on a four-fold rotoinver-
sion axis whereas the chlorine atom of the perchlorate anion is
on a two-fold axis. The perchlorate oxygens are disordered over
two very close positions (see the Experimental section). Fig. 3
shows the structure of the complex [Zn(MeImHS)4]-(ClO4)2
with the expected four-coordinate tetrahedral geometry around
the zinc ion. It is quite evident from the bond angle values S–
Zn–Si of 103.47(1)° and S–Zn–Sii 122.28(3)° (i 0.75 + y, 1.25 − x,
0.25 − z; ii 2 − x, 0.5 − y, z) that deviation from the expected
109.5° is related to a compression along one of the S4 impro-
per rotation axes of the tetrahedron. Thus the coordination
sphere around zinc may be described as a flattened tetrahe-
dron with two longer non-bonding edges (S⋯Siii and Si⋯Siii
distances equal to 4.076(1) Å) and four shorter edges (3.655(1)
Å). Ligand bond distances and angles are comparable to those
previously observed for related compounds (see Table 1), and
to those observed in similar 1,3-dialkyl-imidazole-thione Zn
complexes.16 Each MeImHS molecule is involved in a N–H⋯O
Fig. 2 Main coordination mode of neutral MeImHS: (a) η1-S and of
anion MeImS: (b) η1-N; (c) η1-S; (d) μ-N,S (η1-N, η1-S); (e) η2-N,S.
Table 1 Structurally characterised metal complexes of methimazole with a zinc(II) ion
Complex Mean d(Zn–S) (Å) Geometry/core Reaction/solvent Ref.
[Zn(MeImHS)2Cl2] 2.3405(2) Td/ZnS2Cl2 ZnCl2 + MeImHS/MeOH 12
[Zn(MeImHS)2Br2] 2.340(2) Td/ZnS2Br2 ZnBr2 + MeImHS/MeOH 12
[Zn(MeImHS)2I2] 2.3581(5) Td/ZnS2I2 Zn + MeImHS + I2/CH2Cl2 11b
[Zn(MeImHS)3I]I 2.3746(3) Td/ZnS3I ZnI2 + MeImHS/MeOH 12
[Zn(MeImHS)4](NO3)]·H2O 2.3385(2) Td/ZnS4 Zn(NO3)2 + MeImHS/EtOH 13
[Zn(MeImHS)4](ClO4)2 2.3273(4) Td/ZnS4 Zn(ClO4)2 + MeImHS/EtOH-H2O
a
[Zn4O(MeImS)6]·CHCl3·3H2O
b 2.3375(3) Td/ZnN2OS–ZnOS3 Electrochemical oxidation of the zinc anode in the
presence of MeImHS/CH3CN
14
a This work. b d(Zn–N) = 2.003(10) Å.
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bond (interaction a in Fig. 4a) with perchlorate anions, thus
generating a highly symmetric network constructed by identi-
cal C22(12) chains running along both the [100] and [010] direc-
tions (Fig. 4a). Fig. 4b shows a lateral view of this network
(highlighted in red) sited in the crystal with a packing resem-
bling a bubble pack foil.
Despite the low solubility in water of the complex
[Zn(MeImHS)4](ClO4)2, it readily reacts in the heterogeneous
phase with a diluted aqueous solution of triethylamine to
form an insoluble powder which we failed to crystallise.
The ESI-MS spectrum of the isolated complex and the peak
assignments are shown in ESI-Fig. S1.† The characteristic iso-
topic peaks for zinc-containing ions are clearly identifiable in
the spectrum. The calculated and experimental isotopic
patterns for selected peaks are reported in ESI-Fig. S2.† The
signal with the highest intensity at m/z 291 is due to the
expected [Zn(MeImS)2H]
+ ion. Moreover, as shown by the
signals at m/z 405 and m/z 519, traces of complexes
[Zn(MeImS)3H2]
+ and [Zn(MeImS)4H3]
+, respectively, were
found. Fragmentation of the main species [Zn(MeImS)2H]
+
Table 2 Crystal data collection and reﬁnement parameters for the
compounds [Zn(MeImHS)4](ClO4)2 and [Zn(MeImSMe)2I2]
[Zn(MeImHS)4](ClO4)2 [Zn(MeImSMe)2I2]
Empirical formula C16H24Cl2N8O8S4Zn C10H16I2N4S2Zn
M 720.94 575.56
Crystal system Tetragonal Triclinic
Space group I41/a (no. 88) P1ˉ (no. 2)
a, b, c (Å) 12.3057(4), 12.3057(4),
20.5539(7)
8.9185(11), 9.1511(11),
11.8137(15)
α, β, γ (°) 90, 90, 90 88.66(2), 86.89(2),
71.16(2)
Volume (Å3) 3112.5(2) 911.2(2)
Z 4 2
Temperature (K) 294(2) 294(2)
Dcalc (Mg m
−3) 1.539 2.098
μ (mm−1) 1.280 4.958
θ min-max (°) 1.93–31.70 2.35–31.67
Refl. collected/
unique
16 439/2546
(Rint = 0.023)
9676/5494
(Rint = 0.016)
Data/restraints/
parameters
2546/0/89 5494/0/172
Refl. obs. (I > 2σI) 2085 4482
Final R indices
[I > 2σ(I)]
R1 = 0.0341,
wR2 = 0.1022
R1 = 0.0245,
wR2 = 0.0669
R indices (all data) R1 = 0.0434,
wR2 = 0.1090
R1 = 0.0324,
wR2 = 0.0702
Goodness-of-fit on
F2
1.066 1.050
Largest diﬀ. peak,
hole (e Å−3)
0.42, −0.41 0.89, −0.66
Fig. 3 Displacement ellipsoid model (obtained by Diamond 3.2k) of the
complex [Zn(MeImHS)4](ClO4)2 at the 20% probability level with the
numbering scheme. Only one of the two positions of the disordered
perchlorate anion (see the Experimental section) is shown for clarity.
Symmetry codes: i 0.75 + y, 1.25 − x, 0.25 − z; ii 2 − x, 0.5 − y, z; iii 1.25 −
y, −0.75 + x, 0.25 − z; iv 2 − x, −0.5 − y, z; v 0.25 − y, −0.75 + x, 0.25 − z.
Selected coordination-sphere bond distances (Å) and angles (°): Zn–S
2.3273(4), S–C1 1.712(2); S–Zn–S’ 103.47(1), S–Zn–S’’ 122.28(3); N1–
H1⋯O1’: H1⋯O1’ 2.100(8) Å, N1⋯O1’ 2.940(8) Å, N1–H1⋯O1’ 165.1(3)°.
Fig. 4 Packing views of the complex showing (a) identical C22(12) chains
running along both the [100] and [010] directions; (b) a 3D packing view
evidencing (red) the network depicted in (a). H-atoms have been
omitted for clarity reasons except for those involved in the interactions
shown: a, N1–H1⋯O1’: H1⋯O1’ 2.100(8) Å, N1⋯O1’ 2.940(8) Å, N1–
H1⋯O1’ 165.1(3)°; b, C3–H3⋯O2iv 2.82(1) Å, 3.54(1) Å, 135.9(3)°. Sym-
metry codes: i 0.75 + y, 1.25 − x, 0.25 − z; iv 2 − x, −0.5 − y, z.
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gives, besides the ligand, the [Zn(MeImS)(H2O)]
+ (m/z 195) and
[Zn(MeImS)]+ (m/z 177) species.
Useful information on the nature of the complex [Zn-
(MeImS)2] was also obtained from solid-state MAS
13C-NMR
spectroscopy (ESI-Fig. S3†). Deprotonation of the Zn-bound
methimazole produces the corresponding thionate species in
which the anionic charge is mainly localised on the N–C–S
thioamide fragment (see below). The spectrum of the complex
shows only four resonances showing the equivalence of the
MeImS molecules. As a consequence of (N,S)-coordination to
the Zn-centre, the thioamido carbon C(2) (δ = 145.6) proves to
be the most sensitive to complexation as confirmed by the sig-
nificantly high field shift observed (≈18 ppm) relative to that
of the free ligand. Conversely, carbons C(4) and C(5) are
slightly deshielded (3.1 and 1.0 ppm, respectively) compared
to free MeImHS (δC, 25 °C, MeImHS: CS 163.5, C5 120.0, C4
114.2, NMe 34.0, CHCl3/MeCN 4 : 1 v/v).
11 On the basis of
experimental evidence, it is therefore reasonable to hypo-
thesise for the homoleptic complex [Zn(MeImS)2] that each
MeImS unit binds the metal ion forming a four-membered
(N,S)-chelate.
Theoretical calculations
In recent years, theoretical calculations carried out at the
density functional theory (DFT)17,18 level have been widely
recognised as a reliable tool capable of providing very accurate
information at an acceptable computational cost. In particular,
some authors have exploited DFT calculations to investigate
the nature of diﬀerent ZnII complexes19 and the reactivity of
several systems based on imidazole-2-chalcogenone derivati-
ves.11a,20 Encouraged by these results, we have investigated the
donor properties of the anionic species MeImS by adopting
the well-known B3LYP21 functional along with the 6-31G* all-
electron basis set. Kohn–Sham (KS) HOMO calculated for the
donor is a π-orbital largely localised on the S and N atoms,
antibonding with respect to the CvS bond. KS-HOMO−1 and
HOMO−3 feature the largest contributions from the lone pairs
localised on the sulphur and nitrogen atoms, respectively
(ESI-Fig. S4†). An examination of the natural charges calcu-
lated for MeImS at the optimised geometry reveals that the
nitrogen atom in the 3-position and the exocyclic sulphur
atom display similar negative charges (−0.565 and −0.536 e,
respectively). The Kohn–Sham MO composition and the
charge distribution support the capability of both atoms to
behave as donors, as hypothesised for the complex [Zn-
(MeImS)2] (see above). A view of the optimised complex [Zn-
(MeImS)2] is presented in ESI-Fig. S5† (see ESI-Table S1† for a
list of selected bond lengths and angles). The zinc atom
adopts a distorted tetrahedral geometry with both anions
(N,S)-chelating.
The presented data suggest that the strained four-mem-
bered ring in Zn/MeImS aﬀects the electronic-donation from
the imido and thiocarbonyl groups to the hybrid orbitals of
the zinc ion, thus causing a lower orbital overlap.
The complex [Zn(MeImS)2]: reactivity at the zinc-coordinated
methimazole anion
Picot et al.22a recently reported biomimetics complex-models
featuring diﬀerent cores and charges to study the alkylation
reactions that occur at zinc-bound thiolate in a variety of zinc
sites of enzymes. The reactions of these biomimetic complexes
with methyl iodide led to the formation of thioethers and zinc
complexes containing iodide, allowing the authors to investi-
gate the mechanism of zinc-mediated alkyl group transfer to
thiols.22b–d
In this context, we have investigated the reactivity of the
complex [Zn(MeImS)2] with methyl iodide as the alkylating
agent. The [Zn(MeImS)2] complex may be subject to reactions
that can occur both at the coordinated methimazole and at the
metal centre. As zinc(II) is an ion of borderline hardness, nitro-
gen, sulphur, halogen, and oxygen donor atoms can all be
involved in coordination at the metal centre, with a coordi-
nation number of four, five, or six depending on the ligand
size and charge-transfer ability.8–11,22 Moreover, the lack in d10
metal ions of crystal field stabilisation energy (CFSE) enables a
facile change of the coordination sphere in a reaction.
The reaction between the complex [Zn(MeImS)2] and CH3I
(1 : 2 molar ratio) was carried out in a water/MeOH mixture for
five days. During this time, the suspended complex dissolved
completely with the formation of a clear solution by slow evap-
oration, allowing crystals of stoichiometry [Zn(MeImSMe)2I2]
to form. X-ray diﬀraction analysis was performed on a single
crystal; a displacement ellipsoid model view of the complex is
shown in Fig. 5 and data collection and refinement parameters
are summarised in Table 2.
The zinc(II) centre of the complex is coordinated by two
MeImSMe molecules acting as monodentate N-ligands and
two iodides in a slightly distorted tetrahedral geometry. The
Zn–N and Zn–I bond distances are similar to those in other
zinc complexes reported in the literature.23
Fig. 5 Displacement ellipsoid model (obtained by Diamond 3.2k) of the
complex [Zn(MeImSMe)2I2] at the 20% probability level with the number-
ing scheme. H-atoms are omitted for clarity reasons. Selected coordi-
nation sphere bond distances (Å) and angles (°): Zn–I1 2.5822(5), Zn–I2
2.5852(7), Zn–N1 2.018(2), Zn–N3 2.028(2), S1–C1 1.738(3); S2–C6
1.742(3); I1–Zn–I2 109.75(2), I1–Zn–N1 109.61(6), I1–Zn–N3 112.17(6),
N1–Zn–N3 103.14(8).
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The imidazole rings are planar and the S-Me groups are
oriented through the centre of opposite imidazole rings
with C–H⋯CntIm distances of 2.88 and 2.92 Å for C5–
H5c⋯CntIm(N3−N4) and C10–H10c⋯CntIm(N1−N2), respectively
(c and d interactions in Fig. 6a). Inter-molecular π⋯π inter-
actions between parallel facing Im rings pile up the molecules
in pillars developing along the [011] direction (Fig. 6a). Parallel
pillars weakly interact with each other through C–H⋯I con-
tacts as shown in Fig. 6b.
The interesting reactivity shown by the system
[Zn(MeImS)2]/CH3I led us to test the reaction of the complex
[Zn(MeImS)2] towards hydriodic acid (HI) with the aim of veri-
fying the site of protonation.
The complex [Zn(MeImS)2] was suspended in a water/
MeOH mixture with HI in a 1 : 2 molar ratio. The reaction pro-
ceeded with the complete dissolution of the powder and the
formation of a clear pale yellow solution. After slow evapor-
ation of the solution, white crystals of the complex
[Zn(MeImHS)2I2] were isolated. The X-ray crystal structure
which we recently reported11b features a tetrahedral zinc(II)
centre coordinated by two neutral methimazole units and two
iodides. Since the four-membered ring formed by (N,S)-chelat-
ing thionates is inherently strained,8,9 it is not surprising that
the products separated no longer feature the ZnNCS four-atom
ring. In the case of the reaction with HI we observe the proto-
nation of the imido-nitrogen atom along with the formation of
a Zn–S(thione) bond, leading to the formation of the neutral
complex [Zn(MeImHS)2I2]. In the case of the reaction with
MeI, the methylation reaction occurs on the thionate leading
to the formation of the organic moiety S-methylmethimazole
that binds the Zn centre via the imido-nitrogen atom only.
Being a neutral organic moiety, the charge is balanced by two
coordinating iodides. It is interesting to observe that the
thioether group is uncoordinated to zinc. On this matter, pre-
vious studies22,24,25 have shown that factors such as the charge
and structure at the Zn centre play an important role in
driving the coordinating ability of thioether groups; when
thioethers are part of neutral chelates they result in tetrahedral
complexes which are invariably uncoordinated since a nega-
tively charged ligand (i.e. I−) transfers more charge to Zn2+
than a neutral one.
Reactivity of methimazole towards the ZnN4 core
A large number of structurally characterised Zn-catalytic sites
are four-coordinated tetrahedra, with the zinc bound to three
histidine nitrogens and the fourth site occupied by a water
molecule, as found, for example, in carbonic anhydrases or
phosphate esterases.5c,d To study the interaction of methima-
zole with a ZnN4 coordination sphere, we selected a simple
mononuclear ZnN4 model complex with the 1-methylimidazole
(MeIm) ligands representing the histidine (His) amino acid
residues.26 The complex [Zn(MeIm)4](ClO4)2 was synthesised
according to Chen et al.27 The X-ray crystal structure of this
complex consists of tetrahedral monomeric [Zn(MeIm)4]
2+
cations and the Zn–NMeIm bond lengths (1.991(2) Å) are com-
parable to the Zn–N(His) average bond length found in Zn
proteins as determined by NMR spectroscopy28 (2.09 ± 0.14 Å).
The complex [Zn(MeIm)4](ClO4)2 shows good stability in water
since no relevant changes in its absorption spectrum were
found after 6 h at 25 °C. MeIm in aqueous solution shows a
Fig. 6 Packing views of the complex showing (a) pillars running along the [011] built up through a and b inter-molecular π⋯π interactions; (b)
aligned pillars interacting along the [100] direction. H-atoms have been omitted for clarity reasons except for those involved in the illustrated inter-
actions: a, CntIm(N1−N2)⋯CntIm(N1−N2)i, 3.50 Å, 0°; b, CntIm(N3−N4)⋯CntIm(N3−N4)ii, 3.61 Å, 0°; c, C5–H5c⋯CntIm(N3−N4) 2.88 Å; d, C10–H10c⋯CntIm(N1−N2)
2.92 Å; e, C4–H4a⋯I1iii 3.13 Å. Symmetry codes: i −x, 1 − y, 2 − z; ii −x, 1 − y, 1 − z; iii −1 − x, −y, 1 − z.
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broad absorption band located at 210 nm due to π–π* tran-
sitions of the imidazole ring (Fig. 7b).29 In the absorption
spectrum of [Zn(MeIm)4]
2+ the π–π* transitions are almost
unshifted (band at 212 nm), and a new band at 266 nm due to
the MeIm → Zn ligand-to-metal charge-transfer transition is
observed.31 The complex shows no appreciable absorption
in the region above 400 nm in water, in accord with the d10
electronic configuration of the zinc(II) ion.
The interaction of methimazole with the cationic complex
[Zn(MeIm)4]
2+ was assessed by spectrophotometric titration. By
adding increasing amounts of MeImHS, the band at 266 nm
related to [Zn(MeIm)4]
2+ shifts towards a shorter wavelength,
increasing its absorbance intensity (Fig. 7a), a feature consist-
ent with an interaction altering the ZnN4 core. An isosbestic
point is present at 277 nm, providing evidence for at least one
equilibrium. From eigenvalue analysis of the spectrophoto-
metric data in the 230–300 nm range, three significant eigen-
values were found, indicating that in solution three linearly
independent absorbing species were present (in the
230–300 nm range the absorption of MeIm is negligible),
namely [Zn(MeIm)4]
2+, MeImHS and a newly formed species
identified as the complex [Zn(MeIm)3(MeImHS)]
2+. By fitting
the experimental data considering the equilibrium as in
eqn (1),
½ZnðMeImÞ42þ þMeImHS Ð ½ZnðMeImÞ3ðMeImHSÞ12þ
þMeIm ð1Þ
the complex formation constant of [Zn(MeIm)3(MeImHS)]
2+
was calculated (Kf = 5.82 ± 0.02 M
−1). Any attempt to fit the
experimental data considering zinc complexes with more than
one MeImHS ligand led to unreliable results. The pure spectra
of MeIm, MeImHS, [Zn(MeIm)4]
2+, and [Zn(MeIm)3-
(MeImHS)]2+ are reported in Fig. 7b and the spectral para-
meters of all the absorbing species are reported in Table 3.
These results suggest that the electron-accepting ability of Zn
in the complex29 depends on the set of coordinating ligands.
In this case, the formation of [Zn(MeIm)3(MeImHS)]
2+ species
forecloses the entry of another unit of MeImHS.
Lim pointed out that the catalytic activity of the Zn-His3-
OH2 site is mainly due to the water ligand that transfers the
least charge to the zinc ion and is less bulky compared to the
protein residues.30 In this context, the marked diﬀerence in
charge-transfer ability between MeImHS and water supports
the possibility that MeImHS can interfere with the catalytic
activity of Zn-His3-OH2 metalloenzymes
31 by displacing the Zn-
bound water molecule from the active site.30 The promising
results obtained are a stimulus for further investigations
(beyond the scope of the present study) of the interaction of
methimazole, or of thioamide containing drugs in general,
with mononuclear models representative of [Zn-(XYZ)-(OH2)]
enzymes (where X, Y, Z = His, Asp, Cys, Glu).
Conclusions
New stable complexes of the drug methimazole (MeImHS) and
its anion (MeImS) with zinc ions have been separated and
Fig. 7 (a) Selected spectra collected during the titration of [Zn(MeIm)4]
2+ (8.53 × 10−5 M) with MeImHS (3.50 × 10−4 M) from 0 to 4 MeImHS/
[Zn(MeIm)4]
2+ molar ratio; (b) pure spectra of MeIm, MeImHS, [Zn(MeIm)4]
2+, and [Zn(MeIm)3(MeImHS)]
2+; [T = 25 °C, 0.1 M buﬀer solution pH 9
(borax/hydrochloric acid), 1 cm optical path length].
Table 3 Summary of UV/vis maximum absorption wavelength and
molar absorptivity values for ligands and complexes (aqueous solution,
25 °C, 0.1 M buﬀer solution, pH 9 (borax/hydrochloric acid), 1.0 cm
optical path length)
λmax/nm ε (M
−1 cm−1)
MeIm 210 3691
MeImHS 252 16 300
210 6600
[Zn(MeIm)4]
2+ 266 12 200
212 18 400
[Zn(MeIm)3(MeImHS)]
2+ 256 26 300
210 25 000
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structurally characterised. In the case of [Zn(MeImHS)4]-
(ClO4)2, four neutral ligands are S-coordinated in a distorted
tetrahedral coordination geometry; the Zn–S bond distances
are comparable to the average Zn–S(cysteine) bond lengths
(2.32 Å) found in zinc proteins. Solution studies on the
reaction of methimazole with [Zn(MeIm)4](ClO4)2, selected as
a model compound representing [Zn(His)4]
2+ and [Zn(His)3-
(H2O)]
2+ protein sites, show methimazole displacing only one
of the coordinated MeIm molecules. This evidence supports
the possibility that methimazole, by blocking a histidine/water
binding site, could interfere with the multifunctional roles of
zinc atoms in proteins (e.g. the enzymatic activity of carbonic
anhydrases).5c The anion methimazole can eﬀectively act as a
(N,S)-bridging/chelating ligand to a variety of metal ions due
to its N–C–S functional group. The synthesised homoleptic
complex [Zn(MeImS)2] reveals a diﬀerent reactivity towards the
electrophilic addition of H+ and CH3
+. The MeImS moieties
are N-protonated by HI to form the neutral complex
[Zn(MeImHS)2I2]; conversely, the reaction of [Zn(MeImS)2]
with methyl iodide leads to the formation of the complex
[Zn(MeImSMe)2I2]. This evidence shows that Zn-coordinated
methimazole can markedly modify the coordination environ-
ment when changing from its thione to thionate form, and
vice versa. Within the scope of the study on the interaction of
molecules of pharmacological interest with zinc, these results
underline that methimazole shows a reactivity and a variety of
coordinating modes that may in some way alter the biological
processes that are based on the zinc ion.
Experimental
Materials and instrumentation
Reagents were used as purchased from Aldrich or Fluka.
Elemental analyses were performed using a Fisons Instru-
ments 1108 CHNS elemental analyser. FT-infrared spectra of
powdered samples were recorded with a Thermo-Nicolet 5700
spectrometer from 4000 to 400 cm−1 in the form of pressed
KBr pellets. UV-vis spectrophotometric measurements were
carried out with a Varian Cary 50 spectrophotometer equipped
with a fiber optic dip probe (1 cm optical path length).
13C-NMR spectra were recorded on a Varian 400 MHz spectro-
meter. Chemical shifts are reported in ppm (δ) downfield
from TMS using the same solvent as the internal reference.
The MAS 13C-NMR spectrum was calibrated such that the
observed upfield peak in the spectrum of adamantane is set
to δ = 31.47. Mass spectra were obtained on a QqQ triple
quadrupole Varian 310-MS LC/MS mass spectrometer,
with electrospray ionisation at atmospheric pressure.
The complex tetrakis(1-methylimidazole-N3)zinc(II) diper-
chlorate [Zn(MeIm)4](ClO4)2 was synthesised according to
ref. 27.
Synthesis of complexes
Synthesis of complex [Zn(MeImHS)4](ClO4)2. A mixture of
methimazole (0.100 g, 0.88 mmol) dissolved in 5 mL of
ethyl alcohol and Zn(ClO4)2 hexahydrate (0.082 g,
0.22 mmol) dissolved in 5 mL of water was slightly heated
for 10 min and then stirred for 12 h. A white solid powder
was separated from the solution, washed with an ethyl
alcohol/n-hexane mixture (v/v 1 : 1) and dried in an oven at
50 °C. The filtered solution was slowly concentrated, and
cooled at 10 °C for two days to separate crystals of the
title compound. Yield C16H24Cl2N8O8S4Zn (720.94): calcd C
26.67, H 3.36, N 15.55, S 17.75; found: C 27.0, H 3.4,
N 15.6, S 17.7. δC (100.5 MHz, CDCl3-CH3CN 4 : 1 v/v)
150.7 (CS), 122.4 (C5), 118.0 (C4) 32.5 (N-CH3). IR (KBr, ν/
cm−1): 3127m, 1548m, 1532m, 1420w, 1289w, 1252w, 1235m,
1094s, 957w, 937m, 846w, 828w, 767m, 744m, 674w, 658m,
624m.
Synthesis of complex [Zn(MeImS)2]. The complex [Zn-
(MeImHS)4](ClO4)2 (0.200 g, 0.277 mmol) in 50 mL of water
was reacted with triethylamine (0.39 mL, 2.770 mmol) for 2 h
at room temperature. The solid powder was filtered and
washed several times with ethyl alcohol/water (1 : 1 v/v) to elim-
inate the triethylamine and then dried in an oven at 50 °C.
Yield: 0.066 g, 75%; C8H10N4S2Zn (291.53): calcd C 32.96,
H 3.46, N 19.21, S 21.93; found: C 33.2, H 3.5, N 19.3, S 21.8.
δC (100.5 MHz, solid state) 145.6 (CS), 123.1 (C5), 17.7 (C4),
31.4 (N-CH3). IR (KBr, ν/cm
−1): 3118w, 2940 m, 1536 m,
1456vs, 1414s, 1372vs, 1315s, 1284s, 1144s, 1084 m, 954 m,
732s, 697s, 688s, 517s.
Synthesis of the complex [Zn(MeImSMe)2I2]. The
complex Zn(MeImS)2 (0.100 g, 0.344 mmol) suspended in
20 mL of a water/MeOH mixture (1/1 v/v) and methyl iodide
(0.098 g, 0.688 mmol) were reacted at room temperature for
five days with continuous stirring. In the course of the reaction
the suspended complex dissolved with the formation of a clear
solution. It was filtered to remove traces of solids and allowed
to stand at 5° C. After two days white crystals were
collected and washed with n-hexane. Yield: 0.148 g, 75%;
C10H16I2N4S2Zn (575.41): calcd C 20.87, H 2.80, N 9.73,
S 11.37; found: C 21.0, H 2.9, N 9.9, S 11.4. δC (100.5 MHz,
CDCl3–CH3CN 4 : 1 v/v) 160.9 (C2S), 121.8 (C5), 128.5 (C4), 33.5
(N–CH3), 15.6(S–CH3). IR (KBr, ν/cm
−1): 3119w, 2919w, 1529w,
1462s, 1410s, 1338w, 1283s, 1148vs, 1080w, 970w, 953w, 764vs,
692vs.
Synthesis of the complex [Zn(MeImHS)2I2]. The complex
Zn(MeImS)2 (0.100 g, 0.344 mmol) suspended in 20 mL of a
water/MeOH mixture (1/1 v/v) and hydriodic acid (55 wt% in
water) (0.160 g, 0.688 mmol) dissolved in 5 mL of water were
reacted for two days at r.t. The clear pale yellow solution was
filtered and allowed to stand at 5 °C for three days. A pale
yellow powder was collected and washed with a 1 : 1 (v/v)
mixture of CH2Cl2/n-hexane and then dried in vacuo. Yield:
0.169 g, 90%; C8H12I2N4S2Zn (547.36): calcd C 17.54, H 2.21,
N 10.23, S 11.68; found: C 17.3, H 2.1, N 10.2, S 11.6. δC
(100.5 MHz, CDCl3–CH3CN 4 : 1 v/v) 152.5 (CS), 120.6 (C5),
115.4 (C4) 34.1 (N-CH3). IR (KBr, ν/cm
−1): 3287br,
3163m, 3133m, 1683w, 1573s, 1468s, 1450s, 1404 m, 1280 m,
1155m, 1086 m, 1015w, 920w, 733s, 685m, 667s, 627s, 595m,
510m.
Dalton Transactions Paper
This journal is © The Royal Society of Chemistry 2015 Dalton Trans.
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
1 
A
pr
il 
20
15
. D
ow
nl
oa
de
d 
on
 1
5/
05
/2
01
5 
12
:5
9:
12
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Spectrophotometric measurements
The complex formation constant of [Zn(MeIm)3(MeImHS)]
2+
was determined at 25 °C by spectrophotometric titration
of [Zn(MeIm)4]
2+ (8.53 × 10−5 mmoles) with MeImHS (3.50 ×
10−4 M) in 0.1 M buﬀer solution, pH 9 (borax/hydrochloric
acid). The number of linearly independent absorbing
species was obtained by applying eigenvalues analysis on the
absorbance data matrix.32 The complex formation constant
was obtained using the Hyperquad 2003 program.33
Mass spectrometry
Sample solutions (10 mg L−1) were prepared in CH3CN and
infused directly into the ESI source using a programmable
syringe pump, with a flow rate of 1.50 mL h−1. Needle, shield
and detector voltages were kept at 4500, 800 and 1450 V,
respectively. Pressures of nebulising and drying gas were both
15 psi, and housing and drying gas temperatures were 60 and
50 °C, respectively. The isotopic patterns of the signals in the
mass spectra were analysed using the mMass 5.5.0 software
package.34
X-ray structure determination of [Zn(MeImHS)4](ClO4)2 and
[Zn(MeImSMe)2I2]
A summary of the crystal data and refinement details is given
in Table 2. Intensity data were collected at room temperature
on a Bruker Smart CCD diﬀractometer using graphite-mono-
chromatised Mo-Kα radiation (λ = 0.71073 Å). Datasets were
corrected for Lorentz-polarisation eﬀects and for absorption
(SADABS35). All structures were solved by direct methods
(SIR-9736) and completed by iterative cycles of full-matrix
least-squares refinement on Fo
2 and ΔF synthesis using the
SHELXL-9737 program (WinGX suite).38 Hydrogen atoms
located on the ΔF maps were allowed to ride on their carbon
or nitrogen atoms. In [Zn(MeImHS)4](ClO4)2, the perchlorate
showed high anisotropic displacement parameters for the
oxygen atoms, thus indicating a situation of disorder, which
was subsequently modelled by spitting each oxygen atom
over two close positions, and refining them with an occupancy
factor of 0.5 each. Crystallographic data have been deposited
with the Cambridge Crystallographic Data Centre as sup-
plementary publication no. CCDC-1051219 and CCDC-
1051220.
Computational studies
Theoretical calculations were carried out at the DFT level on
MeImS and Zn(MeImS)2 using the software Spartan ‘10 v. 1.1.0
for Linux (parallel 64-bit version) with the B3LYP hybrid func-
tional.39 The all-electron 6-31G* was adopted for all atomic
species.
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